In fact, ANXA1, LXA4, and RvD1 levels are increased in patients undergoing surgical AAA repair [134], and D-series resolvins inhibit aortic dilatation in experimental murine models of AAA [135]. Here, ANXA1 is linked to triple-A syndrome.